In RB tumors, the correlation of miR-152 levels with ADAM10 and ADAM17 expression was patient-dependent, but miR-152 expression correlated with ADAM expression in RB cell lines displaying significantly decreased miR-152 and concomitantly upregulated ADAM17 and ADAM10 levels. The gene discussed is ADAM17; the disease is retinoblastoma.